Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025)

Inventiva (IVA) recorded quarterly Other Non-Current Liabilities of $1.4 million in Q4 2025, down 99.89% quarter-over-quarter from $1.3 billion in Q2 2025, and up 25.93% on a YoY basis from $1.1 million in Q4 2024.

Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Inventiva's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2025.

  • In Q4 2025, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 25.93% YoY), while the FY2025 annual figure was $1.4 million, up 25.93% from the prior year.
  • Other Non-Current Liabilities was $1.4 million for Q4 2025 at Inventiva, down from $1.3 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 billion in Q2 2025 to a low of $1.1 million in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $214.0 million across 4 years, with a median of $2.1 million in 2021.
  • The sharpest annual moves came in 2021 and 2024: Other Non-Current Liabilities surged 352.77% in 2021, then declined 0.68% in 2024.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $2.9 million in 2021, then slumped by 61.21% to $1.1 million in 2023, then retreated by 0.68% to $1.1 million in 2024, then climbed by 25.93% to $1.4 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $1.4 million (Q4 2025), $1.3 billion (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Inventiva 8.93 Mn -259.80 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.39 Mn
Jun 30, 2025 1.27 Bn
Dec 31, 2024 1.10 Mn
Dec 31, 2023 1.11 Mn
Jun 30, 2021 2.86 Mn
Mar 31, 2021 2.87 Mn
Dec 31, 2020 2.83 Mn
Jun 30, 2020 632,238.11
Dec 31, 2019 635,353.52